BioSpace News Archive

BioCapital

Blood Journal Study: Sickle Cell Anemia Treatment Does Not Increase Malaria Risk in Africa

The drug hydroxyurea does not appear to increase the risk of malaria infection in patients with sickle cell anemia who live in malaria-endemic regions, according to a study published online today in Blood, the Journal of the American Society of Hematology (ASH).

October 19, 2017
·
4 min read
Business

GIMDx and IncellDx Announce OEM and International Distribution Agreement for Single Cell Immuno-Oncology and Oncology Diagnostic Products in China

GIMDx announced today that it has concluded an exclusive OEM and International Distribution agreement for IncellDx single cell immune-oncology and oncology diagnostic products in China.

October 19, 2017
·
3 min read
Business

Jaguar Health Subsidiary Napo Pharmaceuticals Establishes Scientific Advisory Boards for Planned Follow-on Indications for Mytesi, Napo’s FDA-approved Human Prescription Drug

Jaguar Health announced today that its wholly-owned subsidiary, Napo Pharmaceuticals, has established a scientific advisory board for each potential follow-on indication currently planned for Mytesi (crofelemer), Napo’s FDA-approved, first-in-class anti-secretory human prescription drug.

October 19, 2017
·
8 min read
Pharm Country

Immune Pharma Announces Pricing of $18M Public Offering of Convertible Preferred Stock and Warrants

The offering will be comprised of units, priced at a public offering price of $1,000 per unit.

October 19, 2017
·
4 min read
Pharm Country

Medidata Selected for Inaugural Fortune Future 50 List

Medidata, the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it has been selected for the Fortune Future 50 list.

October 19, 2017
·
2 min read
Biotech Beach

Cidara Therapeutics Announces Pricing of $20M Private Placement of Common Stock

The company announced the pricing of a private placement of 3,360,000 shares of its common stock at a price of $6.00 per share.

October 19, 2017
·
3 min read
Deals

Advantage Capital Portfolio Company Cleveland HeartLab, Inc. Acquired by Quest Diagnostics

Advantage Capital portfolio company Cleveland HeartLab, Inc. announced its acquisition by Quest Diagnostics, one of the largest laboratory service providers in the country.

October 19, 2017
·
4 min read
Business

Catalent Announces First Quarter Fiscal Year 2018 Earnings Conference Webcast

Catalent announced that it will release financial results for the first quarter of fiscal year 2018 ended September 30, 2017, before the market open on Monday, November 6, 2017.

October 19, 2017
·
1 min read
Helix BioPharma Corp. Closes Private Placement

Helix BioPharma, an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a private placement financing for gross proceeds of approximately CAD3,909,600.

October 19, 2017
·
3 min read